These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 21820712
1. Immunization with modified vaccinia virus Ankara prevents eczema vaccinatum in a murine model of atopic dermatitis. Oyoshi MK, Wang JY, Geha RS. J Allergy Clin Immunol; 2011 Oct; 128(4):890-892.e3. PubMed ID: 21820712 [Abstract] [Full Text] [Related]
2. Protective murine and human monoclonal antibodies against eczema vaccinatum. Tomimori Y, Kawakami Y, McCausland MM, Ando T, Koriazova L, Kato S, Kawakami T, Crotty S. Antivir Ther; 2011 Oct; 16(1):67-75. PubMed ID: 21311110 [Abstract] [Full Text] [Related]
3. Induction, treatment and prevention of eczema vaccinatum in atopic dermatitis mouse models. Achdout H, Lustig S, Israely T, Erez N, Politi B, Tamir H, Israeli O, Waner T, Melamed S, Paran N. Vaccine; 2017 Jul 24; 35(33):4245-4254. PubMed ID: 28625523 [Abstract] [Full Text] [Related]
4. Development of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infection. Knitlova J, Hajkova V, Voska L, Elsterova J, Obrova B, Melkova Z. PLoS One; 2014 Jul 24; 9(12):e114374. PubMed ID: 25486419 [Abstract] [Full Text] [Related]
6. Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum. Kawakami Y, Tomimori Y, Yumoto K, Hasegawa S, Ando T, Tagaya Y, Crotty S, Kawakami T. J Exp Med; 2009 Jun 08; 206(6):1219-25. PubMed ID: 19468065 [Abstract] [Full Text] [Related]
16. Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis. von Sonnenburg F, Perona P, Darsow U, Ring J, von Krempelhuber A, Vollmar J, Roesch S, Baedeker N, Kollaritsch H, Chaplin P. Vaccine; 2014 Sep 29; 32(43):5696-702. PubMed ID: 25149431 [Abstract] [Full Text] [Related]